Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07442071

Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome

Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome: A Multicenter Randomized and Double-blind Trial.

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
4,336 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.

Conditions

Interventions

TypeNameDescription
DRUGEpinephrine 0.5 mg intravenous bolusEpinephrine 0.5 mg/mL solution for injection, administered as a 0.5 mg intravenous bolus every 3 to 5 minutes during cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest. T
DRUGEpinephrine 1 mg intravenous bolusEpinephrine 1 mg/mL solution for injection, administered as a 1 mg intravenous bolus every 3 to 5 minutes during cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest.

Timeline

Start date
2026-06-01
Primary completion
2030-07-01
Completion
2030-07-01
First posted
2026-03-02
Last updated
2026-03-02

Locations

26 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07442071. Inclusion in this directory is not an endorsement.